Recent Advances in the Diagnosis and Therapy of Primary Adrenal Insufficiency
Journal:
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents
Volume:
2
Page:
251-272
Author(s):
Stefano Laureti, Fausto Santeusanio and Alberto Falorni
Selective Cyclooxygenase-2 Inhibitors and Non-small Cell Lung Cancer
Journal:
Current Medicinal Chemistry
Volume:
9
Page:
1851-1858
Author(s):
C. Gridelli, P. Maione, G. Airoma and A. Rossi
Agents Targeting Ras Signaling Pathway
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
2259-2267
Author(s):
J. E. Dancey
Flavonoids as Anticancer Agents: Structure-Activity Relationship Study
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
2
Page:
691-714
Author(s):
M. Lopez-Lazaro
Inhibition of NF-κB and Proteasome Activity in Tumors: Can We Improve the Therapeutic Potential of Topoisomerase I and Topoisomerase II Poisons
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
1945-1958
Author(s):
Ram Ganapathi, Susan A.J. Vaziri, Masahiro Tabata, Nagio Takigawa, Dale R. Grabowski, Ronald M. Bukowski and Mahrukh K. Ganapathi
Cancer-Homing Toxins
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
1973-1985
Author(s):
H. C. Ng and H. E. Khoo
ETS Proteins and MMPs: Partners in Invasion and Metastasis
Journal:
Current Drug Targets
Volume:
3
Page:
359-367
Author(s):
Sadmeet Singh, Jane Barrett, Kenji Sakata, Richard G. Tozer and Gurmit Singh
STAT Signaling and Cell Function
Journal:
Current Genomics
Volume:
3
Page:
413-423
Author(s):
Fernando de Miguel and Allen C. Gao
TGFb and its Smad Connection to Cancer
Journal:
Current Genomics
Volume:
3
Page:
449-476
Author(s):
S. Thiagalingam, K- h. Cheng, R. L. Foy, H. J. Lee, D. Chinnappan and J. F. Ponte
Biological Activities, Mechanisms of Action and Biomedical Prospect of the Antitumor Ether Phospholipid ET-18-OCH3 (Edelfosine), A Proapoptotic Agent in Tumor Cells
Journal:
Current Drug Metabolism
Volume:
3
Page:
491-525
Author(s):
Consuelo Gajate and Faustino Mollinedo